Literature DB >> 974644

The myth of phenelzine acetylation.

E F Marshall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974644      PMCID: PMC1688643          DOI: 10.1136/bmj.2.6039.817

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE.

Authors:  D A EVANS; K DAVISON; R T PRATT
Journal:  Clin Pharmacol Ther       Date:  1965 Jul-Aug       Impact factor: 6.875

2.  The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine.

Authors:  E C Johnstone
Journal:  Psychopharmacologia       Date:  1976-04-15

3.  The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--I. Studies in vitro.

Authors:  B V Clineschmidt; A Horita
Journal:  Biochem Pharmacol       Date:  1969-05       Impact factor: 5.858

4.  Oxidation of 2-phenylethylhydrazine by monoamine oxidase.

Authors:  K F Tipton; I P Spires
Journal:  Biochem Pharmacol       Date:  1972-01-15       Impact factor: 5.858

5.  The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--II. Studies in vivo.

Authors:  B V Clineschmidt; A Horita
Journal:  Biochem Pharmacol       Date:  1969-05       Impact factor: 5.858

  5 in total
  3 in total

1.  The influence of acetylator phenotype on the outcome of treatment with phenelzine, in a clinical trial.

Authors:  E F Marshall; C Q Mountjoy; I C Campbell; R F Garside; I M Leitch; M Roth
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

2.  Phenelzine: acetylator status and clinical response.

Authors:  G L Sanders; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

3.  Acetylation of phenelzine.

Authors:  W J Tilstone; P Margot; E C Johnstone
Journal:  Psychopharmacology (Berl)       Date:  1979-02-28       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.